20 June 2013
Keywords: Shire, Velaglucerase, Gaucher disease
Article | 03 August 2009
UK drugmaker Shire has reported positive results from the first of three Phase III studies of velaglucerase alfa, its enzyme ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 August 2009
4 August 2009
19 June 2013
© 2013 thepharmaletter.com